Cargando…

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis

The current serological test for human onchocerciasis relies on IgG4 reactivity against the parasite Ov-16 antigen, with reported sensitivities of only 60–80%. As control programs move from control to elimination, it is imperative to identify novel molecules that could improve the serodiagnosis reli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shintouo, Cabirou Mounchili, Ghogomu, Stephen Mbigha, Shey, Robert Adamu, Hotterbeekx, An, Yagmur, Emel, Mets, Tony, Vanhamme, Luc, Colebunders, Robert, Souopgui, Jacob, Njemini, Rose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703281/ https://www.ncbi.nlm.nih.gov/pubmed/34947815 http://dx.doi.org/10.3390/life11121284

Ejemplares similares

In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2020)

Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring
por: Yengo, Bernis Neneyoh, et al.
Publicado: (2022)

Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role?
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2021)

In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases
por: Shey, Robert Adamu, et al.
Publicado: (2019)

Entomological Assessment of Onchocerca Species Transmission by Black Flies in Selected Communities in the West Region of Cameroon
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2020)

Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus
por: Shey, Robert Adamu, et al.
Publicado: (2018)

Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate Against Onchocerciasis and Related Filarial Diseases
por: Shey, Robert Adamu, et al.
Publicado: (2021)

Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein
por: Njume, Ferdinand Ngale, et al.
Publicado: (2019)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus
por: Luz, Sérgio Luiz Bessa, et al.
Publicado: (2014)

Concordance between Ov16 rapid diagnostic test(RDT) and Ov16 enzyme-linked immunosorbent assay (ELISA) for the diagnosis of onchocerciasis in areas of contrasting endemicity in cameroon
por: Ekanya, Relindis, et al.
Publicado: (2023)

Prevalence, correlates of undernutrition and intestinal parasitic infection among children below 5 years living in the forest community of Ndelele, East Region of Cameroon: A cross-sectional assessment
por: Asa, Bertha Fru, et al.
Publicado: (2022)

Ov2 is a modulator of OvHV-2 RTA mediated gene expression
por: Dry, Inga, et al.
Publicado: (2019)

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis
por: Golden, Allison, et al.
Publicado: (2016)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

Nouveau coronavirus (NcOV)
por: Bricaire, François
Publicado: (2013)

Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
por: Luu, Lisa, et al.
Publicado: (2022)

Asymptomatic and sub-microscopic Plasmodium falciparum infection in children in the Mount Cameroon area: a cross-sectional study on altitudinal influence, haematological parameters and risk factors
por: Sumbele, Irene Ule Ngole, et al.
Publicado: (2021)

Evaluation of glycoprotein Ov8 as a potential antigen for an OvHV-2-specific diagnostic assay
por: Alhajri, Salim M., et al.
Publicado: (2018)

Deletion of gene OV132 attenuates Orf virus more effectively than gene OV112
por: Yamada, Yumiko, et al.
Publicado: (2022)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Regulation of Ov2 by virus encoded microRNAs
por: Nightingale, Katie, et al.
Publicado: (2019)

The NR3B subgroup: an ovERRview
por: Tremblay, Annie M., et al.
Publicado: (2007)

The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice
por: Hess, Jessica A., et al.
Publicado: (2016)

Important progress towards elimination of onchocerciasis in the West Region of Cameroon
por: Kamga, Guy-Roger, et al.
Publicado: (2017)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy
por: Djune-Yemeli, Linda, et al.
Publicado: (2022)

Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders’ views
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2019)

Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans
por: George, Parakkal Jovvian, et al.
Publicado: (2019)

Nodding syndrome (NS) and Onchocerca Volvulus (OV) in Northern Uganda
por: Lagoro, David Kitara, et al.
Publicado: (2017)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
por: Kamga, Guy-Roger, et al.
Publicado: (2018)

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs
por: Dissak-Delon, Fanny Nadia, et al.
Publicado: (2017)

Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
por: Vlaminck, Johnny, et al.
Publicado: (2019)

Temperature‐sensitive Ovarian Carcinoma Cell Line (OvBH‐1)
por: Bar, Julia K., et al.
Publicado: (2002)

Adaptation and Validation of the Lithuanian-Language Version of the Olympic Value Scale (OVS)
por: Sukys, Saulius, et al.
Publicado: (2022)

ASimOV: A Framework for Simulation and Optimization of an Embedded AI Accelerator
por: Hwang, Dong Hyun, et al.
Publicado: (2021)

Association Between Ov16 Seropositivity and Neurocognitive Performance Among Children in Rural Cameroon: a Pilot Study
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2021)

The Leopard Kid with White Mane
por: Duman, Deniz D, et al.
Publicado: (2022)

Murine Oviductosomes (OVS) microRNA profiling during the estrous cycle: Delivery of OVS-borne microRNAs to sperm where miR-34c-5p localizes at the centrosome
por: Fereshteh, Zeinab, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r3ii2mgs1jqrmi57j7e6hutd63